about
Prevention and treatment of cryptosporidiosis in immunocompromised patientsPrevention and treatment of cryptosporidiosis in immunocompromised patientsPhylogenomic evidence supports past endosymbiosis, intracellular and horizontal gene transfer in Cryptosporidium parvumParasitic diarrheal disease: drug development and targetsStructure of triosephosphate isomerase from Cryptosporidium parvumOptimization of Benzoxazole-Based Inhibitors of Cryptosporidium parvum Inosine 5′-Monophosphate DehydrogenaseExploring novel strategies for AIDS protozoal pathogens: α-helix mimetics targeting a key allosteric protein–protein interaction in C. hominis thymidylate synthase-dihydrofolate reductase (TS-DHFR)Analysis of monensin sensitivity in Toxoplasma gondii reveals autophagy as a mechanism for drug induced deathLocalized glucose and water influx facilitates Cryptosporidium parvum cellular invasion by means of modulation of host-cell membrane protrusion.Prodrug activation by Cryptosporidium thymidine kinase.Novel anti-Cryptosporidium activity of known drugs identified by high-throughput screening against parasite fatty acyl-CoA binding protein (ACBP)Cryptosporidium parvum has an active hypusine biosynthesis pathway.Successful treatment of cryptosporidiosis in 2 common marmosets (Callithrix jacchus) by using paromomycin.Synthesis, in vitro evaluation and cocrystal structure of 4-oxo-[1]benzopyrano[4,3-c]pyrazole Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase (CpIMPDH) inhibitors.Niche metabolism in parasitic protozoa.Three-dimensional structures in the design of therapeutics targeting parasitic protozoa: reflections on the past, present and future.The state of research for AIDS-associated opportunistic infections and the importance of sustaining smaller research communities.A review of chemotherapeutic approaches to the treatment of cryptosporidiosis.The plastid-derived organelle of protozoan human parasites as a target of established and emerging drugs.An apicomplexan ankyrin-repeat histone deacetylase with relatives in photosynthetic eukaryotesTreatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysisTargeting a prokaryotic protein in a eukaryotic pathogen: identification of lead compounds against cryptosporidiosis.Gene transfer in the evolution of parasite nucleotide biosynthesis.Novel non-active site inhibitor of Cryptosporidium hominis TS-DHFR identified by a virtual screenA cysteine protease inhibitor rescues mice from a lethal Cryptosporidium parvum infectionABC transporters involved in drug resistance in human parasites.Genetic mapping and coccidial parasites: past achievements and future prospects.Necessity of Bumped Kinase Inhibitor Gastrointestinal Exposure in Treating Cryptosporidium Infection.Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy.Contamination of irrigation systems of dental units with Cryptosporidium species in Alexandria, Egypt: a neglected disinfection pitfall.Cryptosporidium parvum IMP dehydrogenase: identification of functional, structural, and dynamic properties that can be exploited for drug design.Efficacy of ginkgolic acids against Cryptosporidium andersoni in cell culture.Classification of Cryptosporidium species from patients with sporadic cryptosporidiosis by use of sequence-based multilocus analysis following mutation scanning.A nanotherapy strategy significantly enhances anticryptosporidial activity of an inhibitor of bifunctional thymidylate synthase-dihydrofolate reductase from Cryptosporidium.Cryptosporidiosis in a buffalo calf at Meerut, Uttar Pradesh and its successful therapeutic management.Present and future control of cryptosporidiosis in humans and animals.Binding mode of inhibitors and Cryptosporidium parvum IMP dehydrogenase: A combined ligand- and receptor-based study.Drug combination therapy in control of cryptosporidiosis in Ludhiana district of PunjabFunctional expression of a DNA-topoisomerase IB from Cryptosporidium parvum.Treating Cryptosporidium parvum infection in calves.
P2860
Q24246356-CCCA6C29-4665-4C2E-9745-5ADE5A654929Q24247353-CD4BCA77-D627-4B48-B63A-36AD7F3AAB55Q24809587-8A65BF2B-B0B3-4614-9D3A-8E839ACA7D55Q26776140-4E1E2160-FF02-4CBD-828E-5C2D30C545B6Q27673567-A3D23FE0-BF99-4E54-86D8-24FECB80F727Q27678115-39015D19-0DA5-45BB-879D-623DB7630634Q27680861-3759513E-1E3A-4380-87D6-97EECFD521F7Q28481550-502ADAEC-A433-4B3A-A61F-D2178BE09A21Q33772004-B7136E6A-1491-4E6F-A414-4C09563EBAD2Q33855150-4C8F2A96-1E9B-4C4C-B46B-F9BE7ECA6A64Q34100267-C70B7ED7-CB64-459B-8AB8-4C7FD25102A5Q34252009-92514DDA-03FB-42EB-9949-54E71D190A0AQ34362529-5BB5417D-2051-43C4-A561-8B500E574D23Q34796395-34C1B3BF-9572-44BC-B575-0AB314D7C582Q35113597-80178C14-DBD3-427F-B9B1-6C112CB9710DQ35592514-0F6DBD08-316F-4A3B-A2AB-F869D0FF44C2Q35739010-0608EA37-CD88-45E5-BF57-A132537D75F7Q35917217-57207720-CAD3-4B8B-8936-A23674ED8472Q36066272-CA7E8D48-5B76-4D7A-934C-33F8F1FE25C9Q36192352-FA61D6D1-ED51-4790-B75A-52BB3C184491Q36388002-44974B3C-4929-4956-A634-D2592444C512Q36740182-FABA18C0-42B3-4CA3-9B5C-D828F296DA9CQ36854287-CFD6DDB2-9B8E-43F3-B530-A3D8FEFF632FQ37117303-644D8CB5-5D70-49CD-92CD-0542D0B86183Q37335883-99F21BC9-31A4-467B-B880-B245A672B274Q37941754-677D4D6B-BCDD-49D3-BC19-EDDA3C1D1847Q38056327-009268E5-D05E-49E9-BD6B-21280BF519E3Q38880229-34726143-01C8-481E-8E70-FE31898ADB5CQ38886453-AF175364-F965-4D73-9E46-81DB920271B5Q39052956-5A348D9D-C7E8-4DFC-9A43-94C8E4834A26Q39541748-DDA6B289-B6B0-4A49-8B6E-63D091CDA6A3Q39545463-B3D84960-FAF6-425F-B39B-B49B62BF8661Q39761854-561A1024-2E4A-44D9-A43E-84B3B7EE00C8Q40143707-1C108328-BEF1-4067-AECA-059694BBE5D3Q40439423-3E7770EC-1BC4-47FD-8C0B-A6DB0C6BE60EQ40460370-3D2A0ED5-E767-4A8D-82A4-28B3842B8323Q41227778-E38CA96E-59ED-4920-B6C9-171C4E805B01Q41811042-0AA39B9E-3058-43C5-86DC-16A06ECF20D5Q42015339-E30AE74E-62A6-48D7-A791-89383AA0FCADQ46167727-A5BCDC58-3223-468C-AB3E-08B1BDDA4B09
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cryptosporidiosis and the challenges of chemotherapy.
@ast
Cryptosporidiosis and the challenges of chemotherapy.
@en
Cryptosporidiosis and the challenges of chemotherapy.
@nl
type
label
Cryptosporidiosis and the challenges of chemotherapy.
@ast
Cryptosporidiosis and the challenges of chemotherapy.
@en
Cryptosporidiosis and the challenges of chemotherapy.
@nl
prefLabel
Cryptosporidiosis and the challenges of chemotherapy.
@ast
Cryptosporidiosis and the challenges of chemotherapy.
@en
Cryptosporidiosis and the challenges of chemotherapy.
@nl
P1476
Cryptosporidiosis and the challenges of chemotherapy.
@en
P2093
Jan R Mead
P356
10.1016/S1368-7646(02)00011-0
P577
2002-02-01T00:00:00Z